15-keto-17-phenyl trinor Prostaglandin F2α
QUICK LINKS
An F-series prostaglandin (PG) analog that has been approved for use as an ocular hypotensive drug.1 Oxidation of the C-15 hydroxyl group and amide hydrolysis of Bimatoprost produces 15-keto-17-phenyl trinor PGF2α. A potential metabolite of Bimatoprost when administered to intact animals and its analogs are potential minor impurities in commercial preparations of their corresponding bulk drug compounds. Although much less potent that the parent compound, 15-keto PGs still retain the ability to produce a small but measurable decrease (1 mm Hg) in the intraocular pressure of normal cynomolgus monkeys when administered at a dose of 1 µg/eye.2 15-keto Latanoprost (15-keto-17-phenyl-13,14-dihydro trinor PGF2α isopropyl ester) is a miotic in the normal cat eye, causing an 8 mm reduction in pupillary diameter at 5 µg/eye. Again, this is not as potent as many other F-type PGs.
15-keto-17-phenyl trinor Prostaglandin F2α References
1 Cantor, L.B. Bimatoprost: a member of a new class of agents, the prostamides, for glaucoma management. Expert 10 721-731 (2001). 2 Stjernschantz, J., Resul, B. Phenyl substituted prostaglandin analogs for glaucoma treatment. Drugs of the Future 17 691-704 (1992).Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
15-keto-17-phenyl trinor Prostaglandin F2α, 1 mg | sc-220624 | 1 mg | $60.00 | |||
15-keto-17-phenyl trinor Prostaglandin F2α, 5 mg | sc-220624A | 5 mg | $270.00 |